BrainStorm Cell Therapeutics
BCLI
#9833
Rank
€1.1 M
Marketcap
0,21 €
Share price
3.51%
Change (1 day)
10.01%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -0,56 €

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -0,53 €. In 2022 the company made an earnings per share (EPS) of -0,60 € an increase over its 2021 EPS that were of -0,61 €.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,56 €-5.41%
2022-0,60 €-2.94%
2021-0,61 €-37.04%
2020-0,97 €1.89%
2019-0,96 €51.43%
2018-0,63 €159.26%
2017-0,24 €-3.57%
2016-0,25 €-37.78%
2015-0,41 €-33.82%
2014-0,61 €36%
2013-0,45 €11.11%
2012-0,41 €50%
2011-0,27 €-50%
2010-0,54 €-233.33%
20090,41 €-142.86%
2008-0,95 €-65%
2007-2,71 €
20050,89 €-108.03%
2004-11,13 €13203.07%
2003-0,08367 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
3,96 €-844.07%🇺🇸 USA
-5,13 € 864.41%🇺🇸 USA
-3,62 € 579.66%🇺🇸 USA
16,66 €-3,228.81%🇺🇸 USA
-0,77 € 44.07%🇺🇸 USA